Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma

被引:48
|
作者
Yu, JunJie [1 ]
Mao, WeiPu [1 ]
Sun, Si [1 ]
Hu, Qiang [1 ]
Wang, Can [1 ]
Xu, ZhiPeng [1 ]
Liu, RuiJi [1 ]
Chen, SaiSai [1 ]
Xu, Bin [2 ]
Chen, Ming [2 ,3 ]
机构
[1] Southeast Univ, Coll Med, Nanjing, Peoples R China
[2] Southeast Univ, Dept Urol, Affiliated Zhongda Hosp, Nanjing, Peoples R China
[3] Southeast Univ, Dept Urol, Affiliated Lishui Peoples Hosp, Nanjing, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
基金
中国国家自然科学基金;
关键词
prognostic signature; The Cancer Genome Atlas; long non-coding RNA; kidney renal clear cell carcinoma; M6A; PARTIAL NEPHRECTOMY; NONCODING RNAS; EXPRESSION; CANCER;
D O I
10.3389/fonc.2021.663263
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose This study aimed to construct an m6A-related long non-coding RNAs (lncRNAs) signature to accurately predict the prognosis of kidney clear cell carcinoma (KIRC) patients using data obtained from The Cancer Genome Atlas (TCGA) database. Methods The KIRC patient data were downloaded from TCGA database and m6A-related genes were obtained from published articles. Pearson correlation analysis was implemented to identify m6A-related lncRNAs. Univariate, Lasso, and multivariate Cox regression analyses were used to identifying prognostic risk-associated lncRNAs. Five lncRNAs were identified and used to construct a prognostic signature in training set. Kaplan-Meier curves and receiver operating characteristic (ROC) curves were applied to evaluate reliability and sensitivity of the signature in testing set and overall set, respectively. A prognostic nomogram was established to predict the probable 1-, 3-, and 5-year overall survival of KIRC patients quantitatively. GSEA was performed to explore the potential biological processes and cellular pathways. Besides, the lncRNA/miRNA/mRNA ceRNA network and PPI network were constructed based on weighted gene co-expression network analysis (WGCNA). Functional Enrichment Analysis was used to identify the biological functions of m6A-related lncRNAs. Results We constructed and verified an m6A-related lncRNAs prognostic signature of KIRC patients in TCGA database. We confirmed that the survival rates of KIRC patients with high-risk subgroup were significantly poorer than those with low-risk subgroup in the training set and testing set. ROC curves indicated that the prognostic signature had a reliable predictive capability in the training set (AUC = 0.802) and testing set (AUC = 0.725), respectively. Also, we established a prognostic nomogram with a high C-index and accomplished good prediction accuracy. The lncRNA/miRNA/mRNA ceRNA network and PPI network, as well as functional enrichment analysis provided us with new ways to search for potential biological functions. Conclusions We constructed an m6A-related lncRNAs prognostic signature which could accurately predict the prognosis of KIRC patients.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Identification of a Three-Glycolysis-Related lncRNA Signature Correlated With Prognosis and Metastasis in Clear Cell Renal Cell Carcinoma
    Li, Tinghao
    Tong, Hang
    Zhu, Junlong
    Qin, Zijia
    Yin, Siwen
    Sun, Yan
    Liu, Xudong
    He, Weiyang
    FRONTIERS IN MEDICINE, 2022, 8
  • [22] Identification of a novel PANoptosis-related gene signature for predicting the prognosis in clear cell renal cell carcinoma
    Yue, Dezhi
    Ren, Congzhe
    Li, Hu
    Liu, Xiaoqiang
    MEDICINE, 2024, 103 (39)
  • [23] Identification of m6A-related lncRNAs-based signature for predicting the prognosis of patients with skin cutaneous melanoma
    Lin, Wentao
    Tan, Zhou-yong
    Fang, Xi-chi
    SLAS TECHNOLOGY, 2024, 29 (01): : 100101
  • [24] Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer
    Yang Song
    Hui Qu
    BMC Cancer, 22
  • [25] Identification of a m6A RNA methylation regulators-based signature for predicting the prognosis of clear cell renal carcinoma
    Jing Chen
    Kun Yu
    Guansheng Zhong
    Wei Shen
    Cancer Cell International, 20
  • [26] Identification of immunogenic cell death-related signature on prognosis and immunotherapy in kidney renal clear cell carcinoma
    Jiang, Silin
    Dong, Yuxiang
    Wang, Jun
    Zhang, Xi
    Liu, Wei
    Wei, Yong
    Zhou, Hai
    Shen, Luming
    Yang, Jian
    Zhu, Qingyi
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [27] Identification of a m6A RNA methylation regulators-based signature for predicting the prognosis of clear cell renal carcinoma
    Chen, Jing
    Yu, Kun
    Zhong, Guansheng
    Shen, Wei
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [28] Construction of an m6A-related lncRNA model for predicting prognosis and immunotherapy in patients with lung adenocarcinoma
    Shen, Hong-Yu
    Zhang, Jin
    Xu, Di
    Xu, Zheng
    Liang, Ming-Xing
    Chen, Wen-Quan
    Tang, Jin-Hai
    Xia, Wen-Jia
    MEDICINE, 2023, 102 (15) : E33530
  • [29] Characterization of m6A-related lncRNA signature in neuroblastoma
    Li, Liming
    Chen, Sisi
    Li, Jianhong
    Rong, Guochou
    Yang, Juchao
    Li, Yunquan
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [30] A cuproptosis-related lncRNA signature identified prognosis and tumour immune microenvironment in kidney renal clear cell carcinoma
    Xin, Sheng
    Mao, Jiaquan
    Cui, Kai
    Li, Qian
    Chen, Liang
    Li, Qinyu
    Tu, Bocheng
    Liu, Xiaming
    Wang, Tao
    Wang, Shaogang
    Liu, Jihong
    Song, Xiaodong
    Song, Wen
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9